TABLE 2.
Age group | Time Period | |||||
---|---|---|---|---|---|---|
| ||||||
Nov 2007–May 2011 | June 2011–Sept 2014 | Oct 2014–Dec 2014 | ||||
|
|
|
||||
No. | (%) | No. | (%) | No. | (%) | |
0–8 mos | 1,831 | (13) | 18,033 | (31) | 462 | (27) |
9 mos–4 yrs | 5,412 | (38) | 16,671 | (28) | 357 | (21) |
5–9 yrs | 2,664 | (19) | 2,846 | (5) | 115 | (7) |
10–14 yrs | 1,222 | (9) | 4,188 | (7) | 141 | (8) |
15–29 yrs | 2,073 | (15) | 12,552 | (21) | 450 | (26) |
30–39 yrs | 331 | (2) | 3,866 | (7) | 169 | (10) |
≥40 yrs | 102 | (1) | 482 | (1) | 23 | (1) |
No data | 507 | (4) | 62 | (0) | 2 | (0) |
Total | 14,142 | (100) | 58,700 | (100) | 1,719 | (100) |
Includes reported measles cases that were laboratory confirmed, epidemiologically linked, and either clinically confirmed (2007–2012) or clinically compatible (2013–2014). Both clinically confirmed and clinically compatible cases were suspected cases with fever and maculopapular (nonvesicular) rash and one of cough, coryza, or conjunctivitis for which no adequate clinical specimens were taken and that were not linked epidemiologically to laboratory-confirmed cases of measles.
SIAs were implemented in October 2007 (nationwide) targeting children aged 9–48 months, during April–May 2011 (nationwide) for children aged 9–95 months, during January–February 2014 (in Regions 3 and 4A and in the National Capital Region) for children aged 6–59 months, and in September 2014 (nationwide) for children aged 9–59 months.